APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-driven Peptide Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032

5 June 2026112 pages

Choose your research edition.

Industry ResearchAI-driven Peptide Drug Discovery Platform Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

According to APO Research, the global AI-driven Peptide Drug Discovery Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-driven Peptide Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI-driven Peptide Drug Discovery Platform market include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI and Insilico Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI-driven Peptide Drug Discovery Platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI-driven Peptide Drug Discovery Platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI-driven Peptide Drug Discovery Platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI-driven Peptide Drug Discovery Platform.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI-driven Peptide Drug Discovery Platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI-driven Peptide Drug Discovery Platform Market by Company

Peptilogics

Pepticom Ltd

Menten AI

GUBRA

Creative Peptides

Exscalate

Generate Biomedicines

Receptor.AI

Insilico Medicine

Schrödinger

BenevolentAI

Evotec

PeptiFinder

Xtalpi

Sun Novo

Zonsen Peplib Biotech

Tide Tron Biotech

AI-driven Peptide Drug Discovery Platform Segment by Type

Design and Generation Platform

Screening and Optimization Platform

Data-driven Platform

Others

AI-driven Peptide Drug Discovery Platform Segment by Application

Scientific Research

Pharmaceuticals

AI-driven Peptide Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-driven Peptide Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-driven Peptide Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-driven Peptide Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI-driven Peptide Drug Discovery Platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021-2026) Table 4. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2027-2032) Table 6. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2026) Table 9. Global AI-driven Peptide Drug Discovery Platform Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI-driven Peptide Drug Discovery Platform Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2026) Table 24. Global AI-driven Peptide Drug Discovery Platform Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI-driven Peptide Drug Discovery Platform Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI-driven Peptide Drug Discovery Platform Industry Trends Table 37. AI-driven Peptide Drug Discovery Platform Industry Drivers Table 38. AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges Table 39. AI-driven Peptide Drug Discovery Platform Industry Restraints Table 40. Global AI-driven Peptide Drug Discovery Platform Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Company (2021-2026) Table 42. Global AI-driven Peptide Drug Discovery Platform Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI-driven Peptide Drug Discovery Platform Key Company Headquarters & Area Served Table 44. Global AI-driven Peptide Drug Discovery Platform Company, Product Type & Application Table 45. Global AI-driven Peptide Drug Discovery Platform Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI-driven Peptide Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Peptilogics Company Information Table 49. Peptilogics Business Overview Table 50. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio Table 52. Peptilogics Recent Development Table 53. Pepticom Ltd Company Information Table 54. Pepticom Ltd Business Overview Table 55. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio Table 57. Pepticom Ltd Recent Development Table 58. Menten AI Company Information Table 59. Menten AI Business Overview Table 60. Menten AI AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 62. Menten AI Recent Development Table 63. GUBRA Company Information Table 64. GUBRA Business Overview Table 65. GUBRA AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio Table 67. GUBRA Recent Development Table 68. Creative Peptides Company Information Table 69. Creative Peptides Business Overview Table 70. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio Table 72. Creative Peptides Recent Development Table 73. Exscalate Company Information Table 74. Exscalate Business Overview Table 75. Exscalate AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio Table 77. Exscalate Recent Development Table 78. Generate Biomedicines Company Information Table 79. Generate Biomedicines Business Overview Table 80. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio Table 82. Generate Biomedicines Recent Development Table 83. Receptor.AI Company Information Table 84. Receptor.AI Business Overview Table 85. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 87. Receptor.AI Recent Development Table 88. Insilico Medicine Company Information Table 89. Insilico Medicine Business Overview Table 90. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio Table 92. Insilico Medicine Recent Development Table 93. Schrödinger Company Information Table 94. Schrödinger Business Overview Table 95. Schrödinger AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio Table 97. Schrödinger Recent Development Table 98. BenevolentAI Company Information Table 99. BenevolentAI Business Overview Table 100. BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 102. BenevolentAI Recent Development Table 103. Evotec Company Information Table 104. Evotec Business Overview Table 105. Evotec AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio Table 107. Evotec Recent Development Table 108. PeptiFinder Company Information Table 109. PeptiFinder Business Overview Table 110. PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio Table 112. PeptiFinder Recent Development Table 113. Xtalpi Company Information Table 114. Xtalpi Business Overview Table 115. Xtalpi AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio Table 117. Xtalpi Recent Development Table 118. Sun Novo Company Information Table 119. Sun Novo Business Overview Table 120. Sun Novo AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio Table 122. Sun Novo Recent Development Table 123. Zonsen Peplib Biotech Company Information Table 124. Zonsen Peplib Biotech Business Overview Table 125. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 127. Zonsen Peplib Biotech Recent Development Table 128. Tide Tron Biotech Company Information Table 129. Tide Tron Biotech Business Overview Table 130. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 132. Tide Tron Biotech Recent Development Table 133. North America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 135. North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2026) Table 136. North America AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America AI-driven Peptide Drug Discovery Platform Market Share Forecast by Country (2027-2032) Table 138. Europe AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2026) Table 141. Europe AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe AI-driven Peptide Drug Discovery Platform Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2026) Table 146. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share Forecast by Country (2027-2032) Table 148. Latin America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2026) Table 151. Latin America AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America AI-driven Peptide Drug Discovery Platform Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2026) Table 156. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI-driven Peptide Drug Discovery Platform Product Image Figure 3. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI-driven Peptide Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 5. Global AI-driven Peptide Drug Discovery Platform Market Share by Region: 2025 VS 2032 Figure 6. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021-2032) Figure 7. North America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Design and Generation Platform Image Figure 13. Global Design and Generation Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Screening and Optimization Platform Image Figure 15. Global Screening and Optimization Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Data-driven Platform Image Figure 17. Global Data-driven Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global AI-driven Peptide Drug Discovery Platform Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global AI-driven Peptide Drug Discovery Platform Market Share by Type 2025 VS 2032 Figure 22. North America AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032) Figure 23. Europe AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032) Figure 25. Latin America AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Share by Type (2021-2032) Figure 27. Scientific Research Image Figure 28. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Pharmaceuticals Image Figure 30. Global Pharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global AI-driven Peptide Drug Discovery Platform Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global AI-driven Peptide Drug Discovery Platform Market Share by Application 2025 VS 2032 Figure 33. North America AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032) Figure 34. Europe AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032) Figure 36. Latin America AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 AI-driven Peptide Drug Discovery Platform Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America AI-driven Peptide Drug Discovery Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America AI-driven Peptide Drug Discovery Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 43. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 46. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 49. Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America AI-driven Peptide Drug Discovery Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 52. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Design and Generation Platform
  • Screening and Optimization Platform
  • Data-driven Platform
  • Others
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Peptilogics
  • Pepticom Ltd
  • Menten AI
  • GUBRA
  • Creative Peptides
  • Exscalate
  • Generate Biomedicines
  • Receptor.AI
  • Insilico Medicine
  • Schrödinger
  • BenevolentAI
  • Evotec
  • PeptiFinder
  • Xtalpi
  • Sun Novo
  • Zonsen Peplib Biotech
  • Tide Tron Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI-driven Peptide Drug Discovery Platform Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2032)
  5. 1.4.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026)
  6. 1.4.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  8. 1.5.1 North America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (2021-2032)
2 AI-driven Peptide Drug Discovery Platform Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Design and Generation Platform
  3. 2.1.2 Screening and Optimization Platform
  4. 2.1.3 Data-driven Platform
  5. 2.1.4 Others
  6. 2.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Type
  7. 2.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global AI-driven Peptide Drug Discovery Platform Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global AI-driven Peptide Drug Discovery Platform Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global AI-driven Peptide Drug Discovery Platform Market Size by Regions
  11. 2.3.1 North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Type (2021-2026)
3 AI-driven Peptide Drug Discovery Platform Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Scientific Research
  3. 3.1.2 Pharmaceuticals
  4. 3.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Application
  5. 3.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global AI-driven Peptide Drug Discovery Platform Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global AI-driven Peptide Drug Discovery Platform Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global AI-driven Peptide Drug Discovery Platform Market Size by Regions
  9. 3.3.1 North America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI-driven Peptide Drug Discovery Platform Industry Trends
  2. 4.2 AI-driven Peptide Drug Discovery Platform Industry Drivers
  3. 4.3 AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges
  4. 4.4 AI-driven Peptide Drug Discovery Platform Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI-driven Peptide Drug Discovery Platform Revenue (2021-2026)
  2. 5.2 Global AI-driven Peptide Drug Discovery Platform Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI-driven Peptide Drug Discovery Platform Key Company Headquarters & Area Served
  4. 5.4 Global AI-driven Peptide Drug Discovery Platform Company, Product Type & Application
  5. 5.5 Global AI-driven Peptide Drug Discovery Platform Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI-driven Peptide Drug Discovery Platform Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI-driven Peptide Drug Discovery Platform Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI-driven Peptide Drug Discovery Platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Peptilogics
  2. 6.1.1 Peptilogics Company Information
  3. 6.1.2 Peptilogics Business Overview
  4. 6.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio
  6. 6.1.5 Peptilogics Recent Developments
  7. 6.2 Pepticom Ltd
  8. 6.2.1 Pepticom Ltd Company Information
  9. 6.2.2 Pepticom Ltd Business Overview
  10. 6.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio
  12. 6.2.5 Pepticom Ltd Recent Developments
  13. 6.3 Menten AI
  14. 6.3.1 Menten AI Company Information
  15. 6.3.2 Menten AI Business Overview
  16. 6.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  18. 6.3.5 Menten AI Recent Developments
  19. 6.4 GUBRA
  20. 6.4.1 GUBRA Company Information
  21. 6.4.2 GUBRA Business Overview
  22. 6.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio
  24. 6.4.5 GUBRA Recent Developments
  25. 6.5 Creative Peptides
  26. 6.5.1 Creative Peptides Company Information
  27. 6.5.2 Creative Peptides Business Overview
  28. 6.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio
  30. 6.5.5 Creative Peptides Recent Developments
  31. 6.6 Exscalate
  32. 6.6.1 Exscalate Company Information
  33. 6.6.2 Exscalate Business Overview
  34. 6.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio
  36. 6.6.5 Exscalate Recent Developments
  37. 6.7 Generate Biomedicines
  38. 6.7.1 Generate Biomedicines Company Information
  39. 6.7.2 Generate Biomedicines Business Overview
  40. 6.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio
  42. 6.7.5 Generate Biomedicines Recent Developments
  43. 6.8 Receptor.AI
  44. 6.8.1 Receptor.AI Company Information
  45. 6.8.2 Receptor.AI Business Overview
  46. 6.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  48. 6.8.5 Receptor.AI Recent Developments
  49. 6.9 Insilico Medicine
  50. 6.9.1 Insilico Medicine Company Information
  51. 6.9.2 Insilico Medicine Business Overview
  52. 6.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio
  54. 6.9.5 Insilico Medicine Recent Developments
  55. 6.10 Schrödinger
  56. 6.10.1 Schrödinger Company Information
  57. 6.10.2 Schrödinger Business Overview
  58. 6.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio
  60. 6.10.5 Schrödinger Recent Developments
  61. 6.11 BenevolentAI
  62. 6.11.1 BenevolentAI Company Information
  63. 6.11.2 BenevolentAI Business Overview
  64. 6.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio
  66. 6.11.5 BenevolentAI Recent Developments
  67. 6.12 Evotec
  68. 6.12.1 Evotec Company Information
  69. 6.12.2 Evotec Business Overview
  70. 6.12.3 Evotec AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio
  72. 6.12.5 Evotec Recent Developments
  73. 6.13 PeptiFinder
  74. 6.13.1 PeptiFinder Company Information
  75. 6.13.2 PeptiFinder Business Overview
  76. 6.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio
  78. 6.13.5 PeptiFinder Recent Developments
  79. 6.14 Xtalpi
  80. 6.14.1 Xtalpi Company Information
  81. 6.14.2 Xtalpi Business Overview
  82. 6.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio
  84. 6.14.5 Xtalpi Recent Developments
  85. 6.15 Sun Novo
  86. 6.15.1 Sun Novo Company Information
  87. 6.15.2 Sun Novo Business Overview
  88. 6.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio
  90. 6.15.5 Sun Novo Recent Developments
  91. 6.16 Zonsen Peplib Biotech
  92. 6.16.1 Zonsen Peplib Biotech Company Information
  93. 6.16.2 Zonsen Peplib Biotech Business Overview
  94. 6.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  96. 6.16.5 Zonsen Peplib Biotech Recent Developments
  97. 6.17 Tide Tron Biotech
  98. 6.17.1 Tide Tron Biotech Company Information
  99. 6.17.2 Tide Tron Biotech Business Overview
  100. 6.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  102. 6.17.5 Tide Tron Biotech Recent Developments
7 North America
  1. 7.1 North America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  3. 7.3 North America AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  3. 8.3 Europe AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  3. 10.3 South America AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst